By Nigam Arora & Dr. Natasha Arora

Signal(s) to enter, add, reduce, exit, hold or change.

MU is long from $21.77.  It is trading at $80.25 as of this writing.  This represents a gain of 267%.


MU reported earnings. Earnings are above consensus but below the whisper number.

Momo crowd had run up the stock going into earnings.  After earnings, the stock is pulling back because earnings came below the whisper numbers.

Increasing Demand

MU is a producer of DRAM and NAND semiconductor memory.  5G and electric vehicles are increasing the demand for memory.

There are shortages of memory across all segments.


The very long term target zone remains $126 to $135.

The recommended position size for the core position is 25% of full core position size.

For those following the Good Way, the Buy Now rating is ‘YES’ on this pullback.  However, if the stock moves higher, the Buy Now rating will change to ‘NO.’

For those following the Best Way, the new buy zone is $69.27 to $77.58.

What To Do Now

Those in the stock with a very long-term horizon may consider continuing to hold.

Those not in the stock may follow the parameters given above.

To take a free 30-day trial to paid services to gain access to more opportunities, please click here.

This post was just published on ZYX Buy Change Alert.

Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE

Please click here to take advantage of a FREE 30 day trial.

Nigam Arora

Nigam Arora

Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.

Dr. Natasha Arora

Dr. Natasha Arora

Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.